Welcome to our dedicated page for Acadia Healthcar SEC filings (Ticker: ACHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to spot how a Medicaid rate change or a new hospital acquisition might impact Acadia Healthcare (ACHC) can mean wading through hundreds of pages of legal and clinical detail. Add Form 4 footnotes on executive stock sales and the puzzle becomes even tougher.
Stock Titan solves that problem. Our AI reads every Acadia Healthcare quarterly earnings report 10-Q filing, annual report 10-K, and 8-K material event the moment it hits EDGAR, then translates dense language into clear takeaways—bed-count trends, payer-mix shifts, EBITDA drivers. Real-time alerts flag Acadia Healthcare Form 4 insider transactions so you never miss meaningful buying or selling.
Wondering where to locate acquisition pipelines or facility occupancy data? Our platform groups filings by topic and adds plain-English summaries, letting you jump straight to revenue segmentation tables, covenant disclosures, or that elusive footnote on regulatory settlements. It’s Acadia Healthcare SEC filings explained simply.
- Track Acadia Healthcare insider trading Form 4 transactions in real time.
- Compare margins across facilities using AI-tagged sections of each 10-Q.
- Dive into the proxy statement executive compensation without reading 80 pages.
- Receive instant context when an 8-K material events explained notice is posted.
From earnings report filing analysis to monitoring executive stock transactions Form 4, Stock Titan streamlines the workflow. Stop combing through exhibits—start understanding Acadia Healthcare SEC documents with AI and make faster, better-informed decisions.
Streeterville Capital LLC, Streeterville Management LLC and John M. Fife filed Amendment No. 1 to Schedule 13G regarding Garden Stage Ltd (Nasdaq: GSIW).
The amendment, dated 29 July 2025, states the reporting persons now hold 0 ordinary shares, equal to 0.0 % of the outstanding class. Their current powers are:
- Sole voting power: 0
- Shared voting power: 0
- Sole dispositive power: 0
- Shared dispositive power: 0
The filing confirms the group’s ownership has fallen below the 5 % threshold that triggers a Schedule 13G, signalling a complete exit from a previously reportable stake. The signatories certify the shares were not acquired or held to influence control of the issuer.
Issuer address: 201, 2/F, China Insurance Group Building, 141 Des Voeux Road Central, Hong Kong. CUSIP: G3730L107.
No financial results or transactional details accompany this disclosure.
Streeterville Capital LLC, Streeterville Management LLC and John M. Fife filed Amendment No. 1 to Schedule 13G regarding Garden Stage Ltd (Nasdaq: GSIW).
The amendment, dated 29 July 2025, states the reporting persons now hold 0 ordinary shares, equal to 0.0 % of the outstanding class. Their current powers are:
- Sole voting power: 0
- Shared voting power: 0
- Sole dispositive power: 0
- Shared dispositive power: 0
The filing confirms the group’s ownership has fallen below the 5 % threshold that triggers a Schedule 13G, signalling a complete exit from a previously reportable stake. The signatories certify the shares were not acquired or held to influence control of the issuer.
Issuer address: 201, 2/F, China Insurance Group Building, 141 Des Voeux Road Central, Hong Kong. CUSIP: G3730L107.
No financial results or transactional details accompany this disclosure.